GlassScriptPhysician profile
Ryan J Pereira
NPI 1033195979
$79,331.80
in general payments reported to CMS, 2019-2025
75 companies · $4,152 in 2025
The $4,152 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $18K · 2021: $7,320 · 2022: $6,905 · 2023: $8,583 · 2024: $5,705 · 2025: $4,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,200 · Food and Beverage: $5,208 · Consulting Fee: $5,040 · Royalty Or License: $649 · Travel and Lodging: $290 · Education: $52.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,200.00 |
| Food and Beverage | $5,208.36 |
| Consulting Fee | $5,040.00 |
| Royalty Or License | $649.26 |
| Travel and Lodging | $290.00 |
| Education | $52.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $38,486.12 | 2019-2025 | Magellan |
| Angiodynamics, INC. | $16,800.00 | 2019-2025 | Venacure 1470 Pro |
| Integra Lifesciences Corporation | $10,825.18 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Crossroads Extremity Systems, LLC | $3,070.37 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,210.43 | 2022-2025 | Motoband |
| Stryker Corporation | $1,083.98 | 2020-2025 | Hoffmann, Infinity Adaptis, Inbone |
| Axogen | $903.64 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Organogenesis INC. | $824.24 | 2020-2025 | Puraply Wound Matrix, Nushield, Affinity |
| Kerecis Limited | $655.14 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $526.95 | 2019-2022 | |
| Smith+Nephew, INC. | $451.34 | 2019-2025 | Grafix Pl, Oasis, Stravix |
| Bard Peripheral Vascular, INC. | $283.58 | 2021-2024 | Venclose Maven Catheter |
| Novo Nordisk INC | $268.16 | 2019-2025 | Wegovy |
| Bioventus LLC | $231.74 | 2021-2024 | Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $220.20 | 2021-2022 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $204.76 | 2019-2023 | Promogran Prisma, Activ.A.C., V.A.C. Veraflo |
| Convatec INC. | $202.80 | 2023-2024 | |
| Stimwave Technologies Incorporated | $192.53 | 2020-2021 | |
| Cardiovascular Systems INC. | $172.03 | 2022 | |
| Boston Scientific Corporation | $168.89 | 2024-2025 | General - Pain Management |
| Amdt Holdings, INC. | $164.84 | 2020 | |
| Orthofix Medical, INC. | $155.66 | 2023-2025 | Truelok, Physio-Stim |
| Curonix LLC | $143.64 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Metric Medical Devices, INC. | $128.58 | 2020 | |
| Paratek Pharmaceuticals, INC. | $125.56 | 2022-2025 | Nuzyra, Xhance |
| Abbott Laboratories | $111.96 | 2021-2023 | Diamondback Peripheral |
| Biocomposites INC | $110.24 | 2021 | |
| Medtronic, INC. | $109.19 | 2022-2025 | Mcgrath Mac |
| Nevro Corp. | $101.02 | 2022 | |
| Access Pro Medical, LLC | $86.91 | 2023-2025 | Matriderm, Matriderm |
| Treace Medical Concepts, INC. | $82.91 | 2022-2025 | |
| Ebi, LLC | $73.39 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Medtronic Vascular, INC. | $70.24 | 2019 | |
| Reprise Biomedical, INC. | $69.94 | 2021-2023 | Miro3d |
| Next Science LLC | $54.79 | 2023-2024 | Xperience, Blastx, Surgx |
| Solventum Corporation | $49.73 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Tei Medical INC. | $44.78 | 2019 | |
| Checkpoint Surgical, INC | $43.81 | 2019-2024 | Checkpoint Stimulators |
| Merck Sharp & Dohme LLC | $42.31 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $39.63 | 2022-2024 | |
| Nalu Medical, INC. | $38.67 | 2021-2025 | Nalu Neurostimulation System |
| Mimedx Group, INC. | $38.50 | 2024-2025 | |
| Misonix INC | $35.21 | 2020 | |
| Averitas Pharma INC. | $35.18 | 2024 | Qutenza |
| Avita Medical Americas, LLC | $34.41 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Acell, INC. | $31.17 | 2019 | |
| Sanofi Pasteur INC. | $31.14 | 2023 | |
| Lilly USA, LLC | $30.87 | 2022-2023 | Mounjaro |
| Medical Device Business Services, INC. | $29.03 | 2024 | Fibulink |
| Wright Medical Technology, INC. | $27.11 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.05 | 2025 | |
| Acera Surgical, INC. | $24.35 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $23.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.42 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $19.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.56 | 2023 | Iovera, Exparel |
| Spr Therapeutics, INC | $18.38 | 2022 | |
| Omeza LLC | $16.58 | 2024 | |
| Team 1, LLC | $16.32 | 2023 | |
| Dynasplint Systems INC. | $15.87 | 2025 | Dynasplint |
| Davol INC. | $15.83 | 2022 | |
| Assertio Therapeutics, INC. | $15.80 | 2019 | |
| Sanara Medtech INC. | $15.65 | 2023 | Celleraterx |
| Melinta Therapeutics, LLC | $15.56 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.95 | 2021 | |
| Hikma Pharmaceuticals USA | $14.95 | 2021 | |
| Alfasigma USA, INC. | $14.71 | 2021 | |
| Pacira Therapeutics, INC. | $14.09 | 2021 | |
| Celularity INC. | $14.00 | 2019 | |
| Allergan, INC. | $13.34 | 2020 | |
| Djo, LLC | $12.96 | 2019 | |
| Advanced Oxygen Therapy INC. | $12.77 | 2022 | |
| Medline Industries LP | $12.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.13 | 2021 | |
| Embody, INC. | $8.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Pereira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.